Factors associated with left atrial size in obese children: an observational study

Osman Ozdemir1, Ayhan Abaci, Samil Hizli

  • 1Clinic of Pediatric Cardiology, Keçiören Training and Research Hospital, Ankara-Turkey. pedkard@gmail.com

Insights

In obese children, left atrial size, a cardiovascular risk indicator, is primarily influenced by age and left ventricular mass. Monitoring left atrial size is crucial for managing childhood obesity risks.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Risk Assessment
  • Obesity Research

Background:

  • Left atrial size is an independent risk factor for cardiovascular diseases.
  • Obesity is a significant risk factor for cardiovascular diseases.
  • Left atrial size may serve as an indicator of obesity-related cardiac risk.

Purpose of the Study:

  • To identify factors affecting left atrial size in obese children without hypertension.
  • To assess the relationship between obesity indicators and left atrial size.
  • To understand cardiac risk indicators in pediatric obesity.

Main Methods:

  • Cross-sectional observational study of 80 obese and 82 lean children.
  • Echocardiographic studies (two-dimensional, M-mode, Doppler).
  • Statistical analyses including t-test, Chi-square, correlation, and multiple regression.

Main Results:

  • Obese children showed increased body weight, BMI, waist circumference, blood pressure, insulin, and insulin resistance.
  • Left atrial size correlated with age, BMI, waist circumference, diastolic blood pressure, insulin resistance, and left ventricular mass.
  • Age and left ventricular mass were the most significant independent factors influencing left atrial size.

Conclusions:

  • Left atrial size in obese children is predominantly affected by age and left ventricular mass.
  • Close monitoring of left atrial size is recommended in cases of childhood obesity.
  • Early identification of cardiac risk factors in obese children is essential.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...